Stay updated on Niraparib vs Placebo Maintenance in Platinum-Sensitive Ovarian Ca Clinical Trial

Sign up to get notified when there's something new on the Niraparib vs Placebo Maintenance in Platinum-Sensitive Ovarian Ca Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Niraparib vs Placebo Maintenance in Platinum-Sensitive Ovarian Ca Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    6 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study record related to a Phase 3 clinical trial evaluating the efficacy of niraparib as maintenance therapy in patients with platinum-sensitive ovarian cancer.
    Difference
    0.1%
    Check dated 2024-06-06T14:38:22.000Z thumbnail image
  7. Check
    21 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria.' The new description provides examples of eligibility criteria, such as a person's general health condition or prior treatments.
    Difference
    10%
    Check dated 2024-05-22T21:00:42.000Z thumbnail image
  8. Check
    43 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T22:18:39.000Z thumbnail image

Stay in the know with updates to Niraparib vs Placebo Maintenance in Platinum-Sensitive Ovarian Ca Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Niraparib vs Placebo Maintenance in Platinum-Sensitive Ovarian Ca Clinical Trial page.